Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Bestova L 2.5mg Tablet

Prescription Icon
Prescription Required

Marketer

Akumentis Healthcare Ltd

Salt Composition

Letrozole (2.5mg)

Overview Bestova L 2.5mg Tablet

Letrozole 2.5mg tablets are indicated for managing breast cancer in women who have gone through menopause. This medication can be administered independently or alongside other therapies like surgical intervention or radiotherapy. It's also employed in advanced breast cancer to inhibit metastasis. Letrozole 2.5mg can be ingested with or without food, always adhering to the physician's prescribed dosage and duration for optimal efficacy. Dosage and frequency are determined by the specific treatment goals. Your physician will tailor the prescription to manage your symptoms effectively. Continuous use is crucial as directed. Common adverse effects include vasomotor flushes, tiredness, diaphoresis, and elevated cholesterol. Report any concerning or persistent side effects to your doctor for potential management strategies. Prior to initiating treatment, disclose any history of hepatic or renal impairment, or osteoporosis. Complete disclosure of all concurrent medications is essential, as interactions can compromise efficacy or alter the drug's action. Inform your physician of any pregnancy or breastfeeding status. Pre-treatment and ongoing monitoring may include blood tests to assess vitamin D levels and bone density.

Uses of Bestova L 2.5mg Tablet

Managing breast cancer

Major Benefits of Bestova L 2.5mg Tablet:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the tablet whole; do not crush, chew, or divide it. Bestova L 2.5mg Tablets can be taken with or without food, although consistent timing is recommended.

Common Side effects of Bestova L 2.5mg Tablet:

  • Dizziness
  • Fatigue
  • Weakness
  • Bone pain
  • Back pain
  • Night sweats
  • Joint pain
  • Nausea
  • Osteoporosis
  • Joint inflammation
  • Weight gain
  • Hot flushes
  • Edema (swelling)
  • Flushing (sense of warmth in the face, ears, neck and trunk)
  • Diaphoresis
  • Bone fracture
  • Hypercholesterolemia (high cholesterol)
  • Cough
  • Shortness of breath

How to use Bestova L 2.5mg Tablet:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. The tablet should be swallowed whole; do not crush, chew, or break it. Bestova L 2.5mg Tablets can be administered with or without food, although consistent timing is recommended.

How Bestova L 2.5mg Tablet works:

Estrogen production is reduced by Bestova L 2.5mg Tablets, a medication classified as an aromatase inhibitor. This lowered estrogen level can inhibit or halt the progression of certain estrogen-dependent breast cancers.

SAFETY ADVICE

AlcoholAlcoholSAFE

There are no known adverse reactions from concomitant use of Bestova L 2.5mg Tablet and alcohol.

PregnancyPregnancyUNSAFE

Using Bestova L 2.5mg tablets while pregnant carries substantial risk. Pregnant women should consult their physician; research in animals and pregnant women indicates significant potential harm to the fetus.

Breast feedingBreast feedingUNSAFE

Lactation and Bestova L 2.5mg tablets are incompatible. Evidence indicates potential infant harm from this medication.

DrivingDrivingUNSAFE

Taking Bestova L 2.5mg tablets might cause drowsiness, blurred vision, or dizziness. Driving should be avoided if these side effects are experienced.

KidneyKidneySAFE IF PRESCRIBED

Patients with kidney disease can generally use Bestova L 2.5mg Tablets without needing a dosage change. Data on its use in patients with end-stage renal disease is scarce, however. Physician consultation is advised.

LiverLiverCAUTION

Individuals with hepatic impairment should use Bestova L 2.5mg Tablets cautiously, as dose modification may be necessary. Physician consultation is advised.

What if you forget to take Bestova L 2.5mg Tablet :

Should you forget to take a Bestova L 2.5mg Tablet, administer it immediately. If, however, your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Never take a double dose.

Facts to Know About Bestova L 2.5mg Tablet

LabelValue
Type of Compound Benzhydryl compound
Addictive None.
Type of Medication Cancer-fighting drugs

FAQs on Bestova L 2.5mg Tablet

Bestova L 2.5mg tablets function as an aromatase inhibitor. This medication is commonly used to manage breast cancer in postmenopausal women, or those whose menstruation has ceased following surgical intervention or chemotherapy.
Letrozole 2.5mg tablets function as an aromatase inhibitor, a class of medication that decreases estrogen levels. This effect is achieved by inhibiting the aromatase enzyme, responsible for estrogen synthesis. Since estrogen fuels the growth of certain breast cancers, termed "estrogen-receptor-positive cancers," lowering estrogen production can impede tumor development.
For advanced breast cancer, or cancer that has metastasized, continued Bestova L 2.5mg Tablet use is advised until disease progression is observed. Following tamoxifen therapy or surgery, Bestova L 2.5mg Tablet administration should continue for five years, or until recurrence, whichever occurs sooner. Alternatively, a sequential regimen of two years of Bestova L 2.5mg Tablet followed by three years of tamoxifen may be employed.
Concurrent use of irbesartan and Bestova L 2.5mg tablets is permissible. Nonetheless, diligent blood pressure monitoring is crucial, as Bestova L 2.5mg tablets can elevate blood pressure. Seek medical advice if blood pressure management proves challenging.
While rare, Bestova L 2.5mg Tablet use has been associated with cataract development. Therefore, report any blurred vision or eye discomfort to your physician promptly.
Experiencing hot flashes might indicate a common side effect of Bestova L 2.5mg Tablet. This is often attributed to reduced estrogen. The incidence of hot flashes typically lessens as your body adapts to Bestova L 2.5mg Tablet. Nevertheless, some individuals may experience these symptoms throughout treatment, with resolution several months post-treatment. For persistent and significant discomfort, seek medical advice for potential management options.
Adverse reactions of significant severity are uncommon with Bestova L 2.5mg Tablet, affecting only a small percentage of patients. Such serious reactions may encompass stroke, angina pectoris, myocardial infarction, thromboembolic events, cataracts, osteoporosis, and severe dermatological manifestations.
Low-dose Bestova (2.5mg) tablets can lead to bone loss (osteoporosis) resulting from reduced estrogen. To monitor for this, your physician might assess your bone mineral density before, throughout, and following your treatment.
The Ministry of Health and Family Welfare designates Bestova L 2.5mg Tablets solely for stimulating ovulation in women with infertility due to a lack of ovulation.
Bestova L 2.5mg Tablet
148
MRP 172
13% off